Skip to main content
Equibles

MORGAN STANLEY

Position in SGMT — Sagimet Biosciences Inc.

CIK 895421 NEW YORK, NY
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$790,213
+$302,685 QoQ
Shares Held
102,227
+9.6% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 122 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. SGMT ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in SGMT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $790,213 102,227
2026-03-31 $487,528 93,307
2025-12-31 $528,323 89,244
2025-09-30 $1,688,087 246,077
2025-06-30 $1,489,663 195,494
2025-03-31 $899,928 276,052
2024-12-31 $1,251,876 278,195
2024-09-30 $751,865 271,432
2024-06-30 $1,160,037 339,193
2024-03-31 $440,205 81,219
2023-12-31 $64,570 11,914
2023-09-30 $153,681 17,464